Navigation Links
Final Patient Enrolled In Large Data Registry of Incisionless Gastric Pouch and Stoma Reduction Procedure

LEXINGTON, Ky., Sept. 17 /PRNewswire/ -- Bluegrass Bariatric Surgical Associates announced today that the final patient has been enrolled in a large, multi-institution registry designed to evaluate the results of an innovative Incisionless gastric pouch and stoma reduction procedure, known as ROSE (Revision Obesity Surgery, Endolumenal). The ROSE procedure reduces the size of a gastric bypass patient's stomach pouch and stoma to approximate the original post-gastric bypass proportions to help them back onto the path of weight loss.

Gastric bypass surgery offers a very effective means to lose weight. It is not, however, always a permanent fix. Up to 44 percent of patients who undergo gastric bypass begin to regain weight -- and the serious co-morbidities associated with it -- a few years after their initial operation.

Bluegrass Bariatrics surgeons G. Derek Weiss, MD, FACS, FASMBS and John Oldham, Jr., MD, FASMBS are participants in the 116-patient, nine-site registry. All the patients entered in the registry will be followed for two years.

"Traditionally, patients who regained weight after gastric bypass had few options to reverse that weight gain because their original surgery make an 'open' revision far too dangerous," said Dr. Weiss, who, along with Dr. Oldham, performed ROSE on 26 of the registry patients. "The ROSE procedure helps overcome the past safety issues of open surgery with very short recovery times and minimal side effects. Our first patient lost 25 pounds in the first month following ROSE. We look forward to following all of our patients to determine the long term results of the procedure which we believe has the potential to dramatically impact bariatric surgery."

To perform ROSE, surgeons use a small, flexible endoscope and a new EndoSurgical Operating System(TM) (EOS) developed by USGI Medical Inc. The EOS is inserted through the mouth and into the stomach pouch. The EOS tools are then used to grasp tissue and deploy suture anchors to create multiple, circumferential tissue folds around the stoma, reducing the diameter of the stoma. If needed, additional anchors are then placed in the stomach pouch to reduce its volume capacity. No cuts are made into the patient's skin during the procedure.

All the patients who participated in the study had lost at least half of their excess weight following an initially successful Roux-en-Y gastric bypass operation, but then subsequently began to regain weight. Researchers will assess the success, duration and safety of the procedure, how much weight the patients lose and changes in their co-morbidities (such as diabetes).

Endoscopic evaluations will be performed at three months and a year after their ROSE procedure to determine the size of their pouch and stoma, as well as how well the anchored tissue folds have held and how their tissue has responded to the anchors.

"Eliminating skin incisions offers important advantages to patients including reduced risk of infection, less post-operative pain, faster recovery time, and no abdominal scars," said Santiago Horgan, M.D., director of the UC San Diego Center for the Treatment of Obesity and director of UCSD's Center for the Future of Surgery, who also participated in the registry. "New flexible surgery tools allow us to utilize the best aspects of laparoscopy and endoscopy to complete new procedures such as ROSE that reduce the trauma associated with more invasive surgery. While the initial clinical evidence has been extremely exciting, standardizing collection and analysis of clinical results across multiple institutions via this registry will provide a more definitive, objective assessment of the benefits of this new surgical technique."

The results of this registry will be submitted for peer-review publication at a later date. All the participating sites received Institutional Review Board approval prior to enrolling patients.

"Obesity rates continue to rise, accelerating the need for safe, effective, more patient-friendly bariatric procedures that can help patients with abnormal weight gain post gastric bypass get back to a healthy weight when diet and exercise have failed," said Gregory L. Schroder, M.D., F.A.C.S. "The ROSE procedure addresses this patient population which may continue to grow as more obese patients undergo primary gastric bypass. We look forward to following our patients and seeing the long term data from this registry."

More than 15 million people in the United States suffer from severe obesity and the numbers continue to rise. Several serious diseases and conditions are commonly associated with obesity, including Type II diabetes, hypertension, sleep apnea and cardiovascular disease. Surgical treatment of obesity has increased significantly in recent years. Over 200,000 individuals in the United States underwent bariatric surgery in 2007, and it is estimated that over 125,000 patients today are candidates waiting for an incisionless revision procedure.

About Bluegrass Bariatric Surgical Associates

The Bariatric Surgery Program at Bluegrass Bariatric Surgical Associates makes a long-term commitment to patients' health and guides them from pre-surgery consultation and testing through surgery, recovery and continuing support. Bluegrass Bariatrics specializes in performing laparoscopic weight-loss surgery throughout Kentucky including adjustable gastric banding, sleeve gastrectomy and Roux-en-Y gastric bypass. Drs. Weiss and Oldham operate at Central Baptist Hospital in Lexington, Baptist East in Louisville, Georgetown Community Hospital in Georgetown, Hazard Regional Hospital in Hazard, and Jackson Purchase Medical Center in Mayfield.

Drs. Weiss and Oldham formed Bluegrass Bariatric Surgical Associates in May of 2003 devoting their entire practice to minimally invasive bariatric surgery. They have performed over 2,500 minimally invasive bariatric surgeries in Kentucky since that time and are certified Center of Excellence Bariatric Surgeons as well as the only BLIScare surgeons in the state.

Dr. Weiss is a Louisville native and board-certified general surgeon, a Fellow of the American College of Surgeons, a Fellow of the American Society of Metabolic and Bariatric Surgery, and a SRC-certified Center of Excellence Bariatric Surgeon. He graduated from Ballard High School, Dartmouth College, University of Louisville School of Medicine and Emory University Department of Surgery. He was a Clinical Instructor with the University of Louisville while in private practice in Louisville from 1994-2002.

Dr. Oldham is an Owensboro native and board certified general surgeon, , a Fellow of the American Society of Metabolic and Bariatric Surgery, and a SRC-certified Center of Excellence Bariatric Surgeon. He graduated from Southern Methodist University, the University of Louisville School Of Medicine and Wright State University Department of Surgery. He practiced privately for three years in Central Kentucky before concentrating his advanced laparoscopic skills on bariatric surgery.

For more information on the Bariatric Surgery Program at Bluegrass Bariatric Surgical Associates or the ROSE procedure, or to schedule a consultation, call 859-543-1577 or visit

Media Contact:

Hollister Hovey

Lazar Partners Ltd.


SOURCE Bluegrass Bariatric Surgical Associates
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Announces Final FDA Approval for Carvedilol Tablets
2. QUANTEL Finalizes the Acquisition of WaveLight Aesthetic GmbH
3. Pro-Consumer Drug Safety Reforms Agreed to in Final FDA Bill; Should End Drug Industry Gaming of Safety System
4. Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center
5. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
6. MEDRAD Plant Named IndustryWeek Magazine Award Finalist
7. Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
8. Seven Finalists Announced for 2007 Insight Award for Customer Advocacy in Healthcare
9. SpectraScience Receives Final European Certification
10. American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children with Diabetes
11. Ten Finalists Chosen for 2007 Hutch Award
Post Your Comments:
(Date:3/29/2017)... ... ... will host an important webinar — Home Health & Hospice: Buying, ... of the webinar will also be made available following its live presentation. The webinar ... still popular targets for healthcare investors. This highly fragmented sector bounced back in 2016, ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... suburbs and South Hills of Pittsburgh now have easier access to the ... only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and ...
(Date:3/29/2017)... ... ... has helped over 1.5 million SharePoint users learn the content management system faster and ... for SharePoint was at the farm level. Enterprises using SharePoint Online in Office 365 ... recently released a modified version of the Help System, VisualSP for Site Collections, which ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati ... to directly address the resolution to globally reduce the harmful use of alcohol ... of FDA and TTB approved ingredients that when infused into alcohol, renders the ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... PHOENIX , March 28, 2017  Today, ... Pharmacy released a new white paper to ... use of latex in healthcare. Specifically, there is substantial confusion ... fact, the FDA has urged manufacturers to drop the term ... labels, because of the challenge to ensure a product is ...
(Date:3/28/2017)... ALBANY, New York , March 28, 2017 /PRNewswire/ ... features a largely consolidated vendor landscape, with the top ... and Agilent Technologies accounting for a significant 49% of ... in a recent report. The vendor landscape is intensely ... large share in the overall market. These factors have ...
(Date:3/28/2017)...  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: ... directors: Christopher Gabrieli , ... as chairman of the board of Akcea Therapeutics. ... Forest Laboratories. Sandford D. Smith , ... "We are excited to announce this expansion to our ...
Breaking Medicine Technology: